| Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy A Ribas, R Dummer, I Puzanov, A VanderWalde, RHI Andtbacka, ... Cell 170 (6), 1109-1119. e10, 2017 | 1330 | 2017 |
| B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells KS Gorski*, M Tseng*, Su-Yi, Otsuji*, X Huang, JE Slansky, SI Pai, ... The Journal of experimental medicine 193 (7), 839-846, 2001 | 1203 | 2001 |
| Effects of an anti-TSLP antibody on allergen-induced asthmatic responses GM Gauvreau, PM O'Byrne, LP Boulet, Y Wang, D Cockcroft, J Bigler, ... New England Journal of Medicine 370 (22), 2102-2110, 2014 | 881 | 2014 |
| Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8 KB Gorden, KS Gorski, SJ Gibson, RM Kedl, WC Kieper, X Qiu, MA Tomai, ... The Journal of Immunology 174 (3), 1259-1268, 2005 | 867 | 2005 |
| Talimogene laherparepvec in combination with ipilimumab in previously untreated, unresectable stage IIIB-IV melanoma I Puzanov, MM Milhem, D Minor, O Hamid, A Li, L Chen, M Chastain, ... Journal of Clinical Oncology 34 (22), 2619-2626, 2016 | 566 | 2016 |
| Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1 AW Tolcher, J Sarantopoulos, A Patnaik, K Papadopoulos, CC Lin, ... Journal of Clinical Oncology 27 (34), 5800-5807, 2009 | 416 | 2009 |
| Cutting edge: expression of functional CD137 receptor by dendritic cells RA Wilcox, AI Chapoval, KS Gorski, M Otsuji, T Shin, DB Flies, K Tamada, ... The Journal of Immunology 168 (9), 4262-4267, 2002 | 341 | 2002 |
| Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor T Shin, G Kennedy, KS Gorski, H Tsuchiya, H Koseki, M Azuma, H Yagita, ... The Journal of experimental medicine 198 (1), 31-38, 2003 | 234 | 2003 |
| Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists KS Gorski, EL Waller, J Bjornton-Severson, JA Hanten, CL Riter, ... International immunology 18 (7), 1115-1126, 2006 | 193 | 2006 |
| First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer AZ Dudek, C Yunis, LI Harrison, S Kumar, R Hawkinson, S Cooley, ... Clinical Cancer Research 13 (23), 7119-7125, 2007 | 181 | 2007 |
| Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy A Ribas, R Dummer, I Puzanov, A VanderWalde, RHI Andtbacka, ... Cell 174 (4), 1031-1032, 2018 | 151 | 2018 |
| Selective modulation of TLR-mediated biological activity JR Fink, KB Gorden, KS Gorski, SK Gupta, X Qiu, JP Vasilakos US Patent 7,485,432, 2009 | 146 | 2009 |
| Efficacy analysis of MASTERKEY-265 phase 1b study of talimogene laherparepvec (T-VEC) and pembrolizumab (pembro) for unresectable stage IIIB-IV melanoma. GV Long, R Dummer, A Ribas, I Puzanov, A VanderWalde, ... Journal of Clinical Oncology 34 (15_suppl), 9568-9568, 2016 | 126 | 2016 |
| Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial R Dummer, DE Gyorki, J Hyngstrom, AC Berger, R Conry, L Demidov, ... Nature medicine 27 (10), 1789-1796, 2021 | 105 | 2021 |
| Primary analysis of a phase 1b multicenter trial to evaluate safety and efficacy of talimogene laherparepvec (T-VEC) and ipilimumab (ipi) in previously untreated, unresected … I Puzanov, MM Milhem, RHI Andtbacka, DR Minor, O Hamid, A Li, ... Journal of Clinical Oncology 32 (15_suppl), 9029-9029, 2014 | 98 | 2014 |
| Immunotherapy of established tumors using bone marrow transplantation with antigen gene–modified hematopoietic stem cells Y Cui, E Kelleher, E Straley, E Fuchs, KS Gorski, H Levitsky, I Borrello, ... Nature medicine 9 (7), 952-958, 2003 | 73 | 2003 |
| B7-DC, Dendritic cell co-stimulatory molecules DM Pardoll, H Tsuchiya, KS Gorski, SY Tseng US Patent 7,030,219, 2006 | 70* | 2006 |
| Homeostasis of human NK cells is not IL-15 dependent H Lebrec, MJ Horner, KS Gorski, W Tsuji, D Xia, WJ Pan, G Means, ... The Journal of Immunology 191 (11), 5551-5558, 2013 | 67 | 2013 |
| Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors T Doi, H Murakami, A Ohtsu, N Fuse, T Yoshino, N Yamamoto, N Boku, ... Cancer Chemotherapy and Pharmacology 68, 733-741, 2011 | 65 | 2011 |
| Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: Findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c … J Malvehy, I Samoylenko, D Schadendorf, R Gutzmer, JJ Grob, JJ Sacco, ... Journal for ImmunoTherapy of Cancer 9 (3), 2021 | 53 | 2021 |
Michael BoedigheimerAmgenVerified email at amgen.com
